Standout Papers
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations (2013)
- Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial (2007)
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial (2013)
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial (2010)
Immediate Impact
8 by Nobel laureates 4 from Science/Nature 133 standout
Citing Papers
Lung cancer
2021 Standout
Targeting the HIF2–VEGF axis in renal cell carcinoma
2020 StandoutNobel
Works of В. А. Горбунова being referenced
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| В. А. Горбунова | 5438 | 4426 | 937 | 2215 | 59 | 7.0k | |
| Oleg Lipatov | 4435 | 4598 | 733 | 1551 | 78 | 6.7k | |
| Ihor Vynnychenko | 4232 | 4448 | 1365 | 1396 | 56 | 6.8k | |
| Carlo L. Bello | 3992 | 3020 | 653 | 3055 | 52 | 7.4k | |
| Mikhail Lichinitser | 3765 | 7634 | 1288 | 1651 | 60 | 9.7k | |
| Paul Bycott | 4423 | 2909 | 553 | 3694 | 50 | 7.0k | |
| Vladimir Moiseyenko | 4049 | 5471 | 1731 | 1017 | 127 | 7.9k | |
| Yasushi Omuro | 3935 | 3880 | 1727 | 1273 | 57 | 6.5k | |
| Bruno Landi | 2815 | 5828 | 1630 | 1511 | 68 | 8.1k | |
| Christopher R. Garrett | 2358 | 2754 | 938 | 1369 | 49 | 5.2k | |
| Andrew Wardley | 3089 | 6636 | 632 | 2001 | 144 | 8.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...